immunity News and Research

RSS

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.

8 Sep 2021

Study finds stark racial, ethnic, and socioeconomic inequities in COVID-19 vaccination rates

In a study of the 9 largest U.S. cities, researchers at Columbia University Mailman School of Public Health found stark racial, ethnic, and socioeconomic inequities in COVID-19 vaccination rates across neighborhoods.

8 Sep 2021

Researchers say modified COVID-19 vaccine boosters should control pandemic

Researchers in Texas have provided evidence for the need to modify the currently used coronavirus disease 2019 (COVID-19) vaccines to match circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Sep 2021

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.

7 Sep 2021

COVID-19 vaccine antibodies inversely related to BMI in obese men, but not women

A new study discusses the role of obesity in COVID-19 and its role in antibody-mediated immune responses to the COVID-19 vaccine.

7 Sep 2021

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

An intriguing new study reports a year-long study in patients with cMCADs from all over France.

7 Sep 2021

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Without the prospect of herd immunity on the immediate horizon, speedy detection for COVID-19 remains imperative for helping to curb the pandemic. Point-of-care testing that can provide immediate results is an urgent need.

7 Sep 2021

Cancer immunotherapies could benefit older patients as much as younger people

A retrospective analysis of large datasets of biomarkers from tumors and healthy tissue by researchers at the Johns Hopkins Kimmel Cancer Center Convergence Institute suggests that older cancer patients could benefit as much as younger patients from cancer immunotherapies.

7 Sep 2021

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

A recent study addresses the effects of controlling non-pharmaceutical interventions to develop a deeper understanding of their influence on the resurgence of COVID-19.

7 Sep 2021

New analysis provides timely information on disparities in vaccine confidence among US adults

A peer-reviewed analysis of US national survey data of 75,000 adults shows, from early January to late March, a near "18 percentage point" increase of adults who have either had the COVID-19 vaccine jab or are willing to do have it.

7 Sep 2021

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Scientists from the National Institutes of Health, USA, have recently demonstrated the immunogenicity and protective efficacy of two vesicular stomatitis virus (VSV)-based coronavirus disease 2019 (COVID-19) vaccines in hamsters.

6 Sep 2021

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

In a recent study, scientists attempt to understand persistent COVID-19 and its implications in patients with hematologic malignancies.

6 Sep 2021

Increased infectivity and immune evasion drive the spread of Delta SARS-CoV-2 variant

Findings suggest infection control measures against variants will need to continue in the post-vaccination era.

6 Sep 2021

Delta variant has a more diverse repertoire of mutations than other variants

In a paper, nearly 2 million SARS-CoV-2 genomes from around the world were analyzed, finding great diversity within the delta variant that exceeds that observed in the more widely spread alpha variant.

6 Sep 2021

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs regarding coronavirus disease (COVID-19). The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Efficacy of vaccines against the SARS-CoV-2 Delta variant

A new study uses statistical models to determine vaccine efficacy against the various SARS-CoV-2 variants and clinical endpoints for SARS-CoV-2 variants.

5 Sep 2021

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

In a recent study published in Reviews in Endocrine and Metabolic Disorders, the researchers discuss the extra-pulmonary manifestations of COVID-19.

5 Sep 2021

Researchers develop the smallest CRISPR to date for genome editing

A compact and efficient CRISPR-Cas system, named CasMINI, could be broadly useful for cell-engineering and gene-therapy applications because it is easier to deliver into cells. The findings appear in a study publishing September 3 in the journal Molecular Cell.

4 Sep 2021

Georgia State researcher receives award to investigate the influence of environment on IBD

Dr. Michal Kuczma, a research assistant professor in the Institute for Biomedical Sciences at Georgia State University, has received a three-year, $270,000 Career Development Award from the Crohn's and Colitis Foundation to study environmental influences on gut microbiota, immunity and inflammation.

4 Sep 2021

Can COVID-19 vaccines affect athletic performance in the short term?

Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.

3 Sep 2021

immunity News and Research

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

Study finds stark racial, ethnic, and socioeconomic inequities in COVID-19 vaccination rates

Researchers say modified COVID-19 vaccine boosters should control pandemic

Highly neutralizing human convalescent plasma reduces lung inflammation in SARS-CoV-2-infected macaques

COVID-19 vaccine antibodies inversely related to BMI in obese men, but not women

Activated mast cell disorders potentially linked to SARS-CoV-2 immunity

Optical biosensors enable fast, accurate, point-of-care COVID-19 diagnosis

Cancer immunotherapies could benefit older patients as much as younger people

Effects of non-pharmaceutical interventions and mutations on COVID-19 resurgence

New analysis provides timely information on disparities in vaccine confidence among US adults

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Implications of persistent SARS-CoV-2 infection in patients with lymphoid malignancies

Increased infectivity and immune evasion drive the spread of Delta SARS-CoV-2 variant

Delta variant has a more diverse repertoire of mutations than other variants

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Efficacy of vaccines against the SARS-CoV-2 Delta variant

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

Researchers develop the smallest CRISPR to date for genome editing

Georgia State researcher receives award to investigate the influence of environment on IBD

Can COVID-19 vaccines affect athletic performance in the short term?

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News